18. Golpanian S, DiFede DL, Pujol MV, et al. Rationale and design of the
allogeneiC human mesenchymal stem cells (hMSC) in patients with aging
fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized,
blinded and placebo controlled trial to evaluate the safety and potential efficacy
of allogeneic human mesenchymal stem cell infusion in patients with aging
frailty. Oncotarget. 2016; 7(11): 11899-912. doi: 10.18632/oncotarget.7727.
19. Barja G, Herrero A. Oxidative damage to mitochondrial DNA is
inversely related to maximum life span in the heart and brain of mammals.
FASEB J. 2000; 14(2): 312-8.
20. Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-
marrow-derived stromal cells to pulmonary alveoli protects against acute lung
injury. Nat Med. 2012; 18(5): 759-65. doi: 10.1038/nm.2736.
21. Sinha P, Islam MN, Bhattacharya S, Bhattacharya J. Intercellular
mitochondrial transfer: bioenergetic crosstalk between cells. Curr Opin Genet
Dev. 2016; 38: 97-101. doi: 10.1016/j.gde.2016.05.002.
22. Holstege H, Pfeiffer W, Sie D, et al. Somatic mutations found in the
healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal
hematopoiesis.
Genome
Res.
2014
May;
24(5):
733-42.
doi:
10.1101/gr.162131.113
Chương 10
1. Erokhin VV, Vasil’eva IA, Konopliannikov AG, et al. [Systemic
transplantation of autologous mesenchymal stem cells of the bone marrow in the
treatment of patients with multidrug-resistant pulmonary tuberculosis]. Probl
Tuberk Bolezn Legk. 2008; (10): 3-6.
2. Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling in asthma. J
Clin Invest. 1999; 104(8): 1001-1006. doi: 10.1172/JCI8124.
3. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev
Med. 2002; 53(1): 477-498.
4. Iyer SS, Co C, Rojas M. Mesenchymal stem cells and inflammatory lung
diseases. Panminerva Med. 2009; 51(1): 5-16.
